Curis (NASDAQ:CRIS) Coverage Initiated at StockNews.com
StockNews.com started coverage on shares of Curis (NASDAQ:CRIS – Free Report) in a research note issued to investors on Sunday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright decreased their target price on Curis from $20.00 to $16.00 and set a “buy” rating for the company in a […]
StockNews.com started coverage on shares of Curis (NASDAQ:CRIS – Free Report) in a research note issued to investors on Sunday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright decreased their target price on Curis from $20.00 to $16.00 and set a “buy” rating for the company in a […]
